Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Peters Malte | Chief Executive Officer, Director | C/O HOOKIPA PHARMA INC., 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK | /s/ Malte Peters | 2025-07-23 | 0001876563 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HOOK | Common Stock | Sale | -$26.8K | -29.2K | -26.84% | $0.92 | 79.5K | Jul 22, 2025 | Direct | F1 |
Id | Content |
---|---|
F1 | This sale was affected pursuant to a "sell to cover" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |